{"id":46662,"date":"2025-01-13T13:04:00","date_gmt":"2025-01-13T13:04:00","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=46662"},"modified":"2025-01-13T13:05:16","modified_gmt":"2025-01-13T13:05:16","slug":"homburger-advises-windward-bio-on-its-usd-200-m-series-a-financing","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/homburger-advises-windward-bio-on-its-usd-200-m-series-a-financing\/","title":{"rendered":"Homburger advises Windward Bio on its USD 200 m Series A Financing"},"content":{"rendered":"<p><strong>On January 10, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases,<\/strong><!--more--><span style=\"font-size: 1rem\">announced its launch with a USD 200 m series A financing from lead investors OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and co-investors SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital and Pivotal bioVenture Partners. Windward Bio has entered into an agreement to license WIN378, a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP), from Kelun-Biotech and Harbour BioMed for global rights, excepting China and select smaller markets in Asia.<\/span><\/p>\n<p>Proceeds from the financing will be used to develop a phase 2-ready, long-acting anti-TSLP antibody with best-in-class potential in asthma and chronic obstructive pulmonary disease (COPD).<\/p>\n<p>Homburger AG advises Windward Bio on its set-up and financing. The Homburger team comprises Andreas M\u00fcller, Margrit Marti, Oliver Kneub\u00fchl, Kaiyan Yeo, Eric Huber, Jonas St\u00e4hli, Rebecca Sigrist and Carolina Rodriguez (all Corporate \/ M&amp;A), Stefan Oesterhelt and Juliette Buob (both Tax) and Luca Dal Molin (IP \/ IT).<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-46662","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/46662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=46662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}